Soumit Roy
Stock Analyst at Jones Trading
(3.47)
# 899
Out of 5,124 analysts
46
Total ratings
34.29%
Success rate
12.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WHWK Whitehawk Therapeutics | Initiates: Buy | $7 | $2.76 | +153.62% | 1 | Dec 22, 2025 | |
| CNTX Context Therapeutics | Initiates: Buy | $7 | $2.28 | +207.02% | 1 | Dec 22, 2025 | |
| EVAX Evaxion | Initiates: Buy | $10 | $3.36 | +197.62% | 1 | Oct 30, 2025 | |
| AVXL Anavex Life Sciences | Downgrades: Hold | n/a | $4.10 | - | 1 | Oct 24, 2025 | |
| ATYR aTyr Pharma | Downgrades: Hold | n/a | $0.90 | - | 2 | Sep 15, 2025 | |
| CGON CG Oncology | Initiates: Buy | $50 | $50.36 | -0.71% | 1 | Sep 8, 2025 | |
| TARA Protara Therapeutics | Initiates: Buy | $21 | $6.65 | +215.79% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $21.86 | +82.98% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $29.42 | -8.23% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.67 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.89 | - | 2 | May 16, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $15 | $5.34 | +180.90% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $5.70 | +75.44% | 1 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $34 | $26.52 | +28.21% | 2 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $36 | $1.99 | +1,709.05% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.50 | +1,180.00% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $8.32 | +8.17% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $10.42 | +63.15% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.82 | +614.29% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $96 → $64 | $7.03 | +810.38% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.03 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $5.77 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $12.23 | +112.59% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $13.07 | +435.58% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $57.86 | -82.72% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.19 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $11.27 | +609.85% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.70 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $1.04 | +30,669.23% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $3.80 | +21,215.79% | 1 | Feb 24, 2021 |
Whitehawk Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.76
Upside: +153.62%
Context Therapeutics
Dec 22, 2025
Initiates: Buy
Price Target: $7
Current: $2.28
Upside: +207.02%
Evaxion
Oct 30, 2025
Initiates: Buy
Price Target: $10
Current: $3.36
Upside: +197.62%
Anavex Life Sciences
Oct 24, 2025
Downgrades: Hold
Price Target: n/a
Current: $4.10
Upside: -
aTyr Pharma
Sep 15, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.90
Upside: -
CG Oncology
Sep 8, 2025
Initiates: Buy
Price Target: $50
Current: $50.36
Upside: -0.71%
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $6.65
Upside: +215.79%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $21.86
Upside: +82.98%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $29.42
Upside: -8.23%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.67
Upside: -
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.89
Upside: -
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $5.34
Upside: +180.90%
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $5.70
Upside: +75.44%
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $26.52
Upside: +28.21%
Feb 11, 2025
Upgrades: Buy
Price Target: $36
Current: $1.99
Upside: +1,709.05%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.50
Upside: +1,180.00%
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $8.32
Upside: +8.17%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $10.42
Upside: +63.15%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.82
Upside: +614.29%
Sep 11, 2024
Maintains: Buy
Price Target: $96 → $64
Current: $7.03
Upside: +810.38%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.03
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $5.77
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $12.23
Upside: +112.59%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $13.07
Upside: +435.58%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $57.86
Upside: -82.72%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $2.19
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $11.27
Upside: +609.85%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.70
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $1.04
Upside: +30,669.23%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $3.80
Upside: +21,215.79%